Overview
Bioscientia is a biotechnology company conducting research and development on rapid, sensitive LFD diagnostic tests and animal health protection products. It supplies tests for detecting animal pathogens for veterinary professionals and individual customers.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 40 days late).
- 202519/06/2026
- 202418/06/2025
- 202306/06/2024
- 202219/06/2023
- 202124/08/2022
- 202004/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Biotechnology research
- Veterinary diagnostic tests
- LFD diagnostic tests
- Animal health products
Website technology
- Website
- WordPress
Public procurement
Bioscientia is the contractor in one public sector contract, worth USD 8.78k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Jul 14, 2026 | Bioinformatics service | $8,785 | Instytut Chemii Bioorganicznej Polskiej Akademii Nauk |
Authorized Representatives
Manner of representation
If the management board consists of more than one person, each member of the management board is authorised to represent the company, incur liabilities and make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Belterage 42 | 99 | $1,337.12 | 99% |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
19 public aid cases recorded, with a total value of $2,430,347.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 9, 2026 | Aid for research and development projects: industrial research | $453.8K$453,803 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Mar 9, 2026 | Aid for research and development projects: experimental development | $179.2K$179,239 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jan 12, 2025 | Aid for research and development projects: industrial research | $345.2K$345,178 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
7 projects co-financed from European Funds recorded, with total EU co-financing of $2,649,536.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-07-01 | A new method for detecting trichinella infection | $633K$633,041 | European Funds for a Modern Economy | |
| 2025-02-01 | Innovative diagnostic test for field diagnosis of tapeworm infection in horses | $715.6K$715,569 | European Funds for a Modern Economy | |
| 2021-10-01 | Development of an innovative preparation to increase the vitality and productivity of the honey bee (Apis mellifera) | $282.6K$282,624 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| SKIN Lab Internationalsp. z o.o. | $295,930.15 | skinlab.pl | ||
| FcbiotechS.A. | $246,877.92 | fcbiotech.pl | ||
| Genelyticasp. z o.o. | $213,207.91 | genelytica.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| GMT Foodsafetysp. z o.o. | $207,064.75 | gmtfoodsafety.com | ||
| Countess Laboratoriessp. z o.o. | $164,970.29 | countess.pl | ||
| AM Lab Solutionssp. z o.o. | $100,896.70 | amsolutions.pl |
FAQ
Last updated: 2026-06-19